Optimal delivery of male breast cancer follow-up care: improving outcomes

Raina M Ferzoco, Kathryn J Ruddy Department of Oncology, Mayo Clinic, Rochester, MN, USA Abstract: Male breast cancer is a rare disease. There are limited data to inform optimal treatment and follow-up strategies in this population. Currently, most follow-up guidelines are drawn from the vast liter...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ferzoco RM, Ruddy KJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/e83f87cc453a49968f66d52edf71ba13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e83f87cc453a49968f66d52edf71ba13
record_format dspace
spelling oai:doaj.org-article:e83f87cc453a49968f66d52edf71ba132021-12-02T07:18:44ZOptimal delivery of male breast cancer follow-up care: improving outcomes1179-1314https://doaj.org/article/e83f87cc453a49968f66d52edf71ba132015-11-01T00:00:00Zhttps://www.dovepress.com/optimal-delivery-of-male-breast-cancer-follow-up-care-improving-outcom-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Raina M Ferzoco, Kathryn J Ruddy Department of Oncology, Mayo Clinic, Rochester, MN, USA Abstract: Male breast cancer is a rare disease. There are limited data to inform optimal treatment and follow-up strategies in this population. Currently, most follow-up guidelines are drawn from the vast literature on female breast cancer, despite the fact that male breast cancer has unique biological characteristics. In this review, we discuss clinical characteristics of male breast cancer as well as current best practices for long-term care with a focus on surveillance, screening, and treatment-related symptom management in male breast cancer survivors. Keywords: male breast cancer, follow-up, surveillance, screeningFerzoco RMRuddy KJDove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 371-379 (2015)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ferzoco RM
Ruddy KJ
Optimal delivery of male breast cancer follow-up care: improving outcomes
description Raina M Ferzoco, Kathryn J Ruddy Department of Oncology, Mayo Clinic, Rochester, MN, USA Abstract: Male breast cancer is a rare disease. There are limited data to inform optimal treatment and follow-up strategies in this population. Currently, most follow-up guidelines are drawn from the vast literature on female breast cancer, despite the fact that male breast cancer has unique biological characteristics. In this review, we discuss clinical characteristics of male breast cancer as well as current best practices for long-term care with a focus on surveillance, screening, and treatment-related symptom management in male breast cancer survivors. Keywords: male breast cancer, follow-up, surveillance, screening
format article
author Ferzoco RM
Ruddy KJ
author_facet Ferzoco RM
Ruddy KJ
author_sort Ferzoco RM
title Optimal delivery of male breast cancer follow-up care: improving outcomes
title_short Optimal delivery of male breast cancer follow-up care: improving outcomes
title_full Optimal delivery of male breast cancer follow-up care: improving outcomes
title_fullStr Optimal delivery of male breast cancer follow-up care: improving outcomes
title_full_unstemmed Optimal delivery of male breast cancer follow-up care: improving outcomes
title_sort optimal delivery of male breast cancer follow-up care: improving outcomes
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/e83f87cc453a49968f66d52edf71ba13
work_keys_str_mv AT ferzocorm optimaldeliveryofmalebreastcancerfollowupcareimprovingoutcomes
AT ruddykj optimaldeliveryofmalebreastcancerfollowupcareimprovingoutcomes
_version_ 1718399551729041408